People: 4-D Neuroimaging (FDNU.PK)

FDNU.PK on OTC Markets Group

0.00USD
20 Mar 2012
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.00
Open
--
Day's High
$0.00
Day's Low
$0.00
Volume
500
Avg. Vol
0
52-wk High
$0.02
52-wk Low
$0.00

Search Stocks

Summary

Name Age Since Current Position

D. Scott Buchanan

 45 2000 President, Chief Executive Officer, Principal Financial Officer, Director

Eugene Hirschkoff

 61 2000 Vice President - Engineering, Secretary

Kenneth Squires

 59 1996 Vice President, Marketing

Martin Egli

 51 1995 Director

Galleon Graetz

 49 1998 Director

Hans-Ueli Rihs

 60 2001 Director

Martin Velasco

 50 2000 Director
» Insider Trading

Biographies

Name Description

D. Scott Buchanan

 Scott Buchanan, Ph.D is the Company’s president and chief executive officer and has served as a member of the board of directors since 1997. He joined the Company in 1986. He served as vice president, product operations from February 1992 through December 1996 and has served as president since December 1996, chief executive officer since March 1997 and principal financial officer since November 2000. Dr. Buchanan has been involved with product and applications development since joining the Company as a staff physicist. Dr. Buchanan received a B.S. in Physics from Lehigh University in Pennsylvania and an M.S. and Ph.D. in Physics from the University of Illinois. Dr. Buchanan was elected to the Company’s board of directors in 1997. Dr. Buchanan is a citizen of the United States.

Eugene Hirschkoff

 Eugene C. Hirschkoff, Ph.D. (age 61) is the Company’s vice president, engineering. He joined the Company in 1971, and has served in many capacities in engineering, technology development and manufacturing. From 1990 through 1996, he served as director of clinical applications, managing the Company’s research and development programs with its collaboration partners at the Scripps Clinic and Research Foundation and the University of California at San Francisco among others. Dr. Hirschkoff is responsible for the Company’s FDA compliance programs. In December 1997 he was appointed vice president, engineering and in November 2000 he was appointed corporate secretary. Dr. Hirschkoff received his B.A. in Physics and Mathematics at Reed College in Oregon; M.A. in Physics at Harvard University; Ph.D. in Physics from the University of California, San Diego; MBA from the State University of California, San Diego and his J.D. from the University of San Diego. Dr. Hirschkoff is a citizen of the United States.

Kenneth Squires

 Kenneth C. Squires, Ph.D. (age 59) is the Company’s vice president, marketing. He joined the Company in September 1988. Since that time he has held various positions as director of clinical applications and director of neuroscience applications-marketing and was appointed vice president, marketing in December 1996. Dr. Squires received his B.S. and M.S. degrees in Aeronautical Engineering at the University of Minnesota and his Ph.D. in Experimental Psychology from the University of California, San Diego. Dr. Squires is a citizen of the United States.

Martin Egli

 Martin P. Egli (age 51) is the chairman of the Company’s board of directors and a member of the Company’s audit committee. He has served since 1993 as a partner and principal of Swisspartners Investment Network AG ("Swisspartners"), a company that provides investment management, corporate finance and trust services. Swisspartners is a principal shareholder of 4-D. Mr. Egli is a director of several privately-held companies and was elected to the Company’s board of directors in 1995. Mr. Egli is a citizen of Switzerland.

Galleon Graetz

 Dr. Galleon Graetz (age 49) is a member of the Company’s board of directors. He served as clinical consultant and co-director of the internal medicine division of the Swiss Hospital School of Nursing from 1990 to 1997. Dr. Graetz is currently a senior partner of Care Net AG, a health consulting company, and currently involved as part of the management team at Medizinisches Zentrum Romerhof, a unique health care provider located in Zurich. Dr. Graetz was educated in internal medicine and radiology in Switzerland and Israel. Dr. Graetz was elected to the Company’s board of directors in 1998. Dr. Graetz is a citizen of Switzerland.

Hans-Ueli Rihs

 Hans-Ueli Rihs (age 60) is a member of the Company’s board of directors. He served as international sales director and board member of PHONAK Holding, Ltd., Hearing Instruments and Systems for the Hard of Hearing, in Stafa, Switzerland from 1976 to 1999. Since 2000 he has been an independent entrepreneur and investor. He currently serves as a board member of PHONAK, Swisspartners and Mespas Ltd. He was elected to the Company’s board of directors in 2001 in connection with the purchase by Swisspartners of 14,751,153 shares of the Company’s common stock in a private placement transaction. Mr. Rihs is a citizen of Switzerland.

Martin Velasco

 Martin Velasco (age 48) is a member of the Company’s board of directors and audit committee. He is an entrepreneur with extensive experience in the electronic communications industry, combining the experience of large international companies with high-tech start-ups. In the last three years he also has developed significant activities in the medical and biotech areas. Martin Velasco holds an engineering degree in electronics, a postgraduate degree in computer science from the EPFL Lausanne and an MBA from INSEAD. Martin Velasco serves on several boards of high-tech start-ups in Europe and United States, as well as venture and investment funds. Mr. Velasco was elected to our board of directors in 2000. He is a member of the Business Steering Committee of the Global Business Dialog for Electronic Commerce, member of the World Economic Forum Digital Divide Task Force and Chairman of the Investment Committee of the Positive Fund. Mr. Velasco is also the Chairman of the charity Infantia Foundation he founded in 1999, which has the objective to help children in the developing world. Mr. Velasco is a citizen of Spain.

Basic Compensation

Name Fiscal Year Total

D. Scott Buchanan

 177,792

Eugene Hirschkoff

 143,576

Kenneth Squires

 147,701

Martin Egli

 --

Galleon Graetz

 --

Hans-Ueli Rihs

 --

Martin Velasco

 --
As Of 29 Sep 2003

Options Compensation

Name Options Value

D. Scott Buchanan

 1,765,376 0

Eugene Hirschkoff

 785,833 0

Kenneth Squires

 771,233 0

Martin Egli

 0 0

Galleon Graetz

 0 0

Hans-Ueli Rihs

 0 0

Martin Velasco

 0 0

Insider Trading

» Full list on Insider Trading
Search Stocks